🧬 What is 5-HTP?
-
Full Name: 5-Hydroxytryptophan (also called oxitriptan)
-
Origin: A naturally occurring amino acid; extracted commercially from the African plant Griffonia simplicifolia
-
Function: Intermediate between tryptophan and serotonin in the body
-
Main Action: Increases serotonin levels in the brain and central nervous system
🧠 Why Serotonin MattersLow serotonin is associated with:
🌿 Where 5-HTP Is Found
-
Not present in significant quantities in food
-
Tryptophan (precursor to 5-HTP) is found in:
Turkey, milk, potatoes, pumpkin, greens
✅ Common Uses / Benefits
Condition |
How 5-HTP May Help |
Depression |
Boosts serotonin levels, may work similarly to SSRIs |
Fibromyalgia |
Improves sleep, reduces pain and anxiety |
Insomnia |
Helps induce sleep, delay wake time |
Migraines/Headaches |
Reduces frequency and severity |
Obesity & Carbohydrate Cravings |
May reduce appetite, especially for carbs |
💊 Dosage Guidelines
-
Typical range: 50–100 mg/day
-
Higher doses (e.g., 300 mg) used in some depression studies
-
Start low: Many begin with 20–50 mg
-
Best taken: On an empty stomach
-
Alternate methods: Sublingual use (under the tongue) reported by some users
⚠️ Side Effects & Precautions
Risk |
Description |
Common side effects |
Nausea, vomiting, drowsiness, diarrhea, sexual issues |
Serious concern |
Eosinophilia-myalgia syndrome (EMS) – possibly linked to contaminants |
Pregnancy/Breastfeeding |
Possibly unsafe – avoid use |
Down syndrome |
Linked to seizures in some users – avoid use |
❌ Drug Interactions – DO NOT COMBINE with:
Drug Category |
Examples |
Why |
SSRIs / Antidepressants |
Prozac, Zoloft, Paxil, Elavil |
Risk of serotonin syndrome |
MAOIs |
Nardil, Parnate |
Dangerous serotonin overload |
Cough meds with Dextromethorphan |
Robitussin DM |
Can lead to serotonin syndrome |
Painkillers |
Meperidine (Demerol), Tramadol (Ultram), Pentazocine (Talwin) |
Increased risk of serotonin-related side effects |
Carbidopa (used for Parkinson’s) |
Lodosyn |
May cause behavioral side effects like anxiety, rapid speech |
📂 Additional Resources
Research studies / References |
 |
a b Turner EH, Blackwell AD (2005). "5-Hydroxytryptophan plus SSRIs for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin". Medical Hypotheses 65 (1): 138-44. doi:10.1016/j.mehy.2005.01.026. PMID 15893130.
http://linkinghub.elsevier.com/retrieve/pii/S0306-9877(05)00068-X. |
|
|
 |
Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. ISBN 3-88763-075-0. http://books.google.com/?id=5GpcTQD_L2oC&lpg=PA1528&pg=PA773#v=onepage. |
|
|
 |
a b Shaw K, Turner J, Del Mar C (2002). "Tryptophan and 5-hydroxytryptophan for depression". Cochrane Database of Systematic Reviews (Online) (1): CD003198. doi:10.1002/14651858.CD003198. PMID 11869656. |
|
|
 |
Rahman MK, Nagatsu T, Sakurai T, Hori S, Abe M, Matsuda M (1982). "Effect of pyridoxal phosphate deficiency on aromatic L-amino acid decarboxylase activity with L-DOPA and L-5-hydroxytryptophan as substrates in rats". Jpn. J. Pharmacol. 32 (5): 803-11. doi:10.1254/jjp.32.803. PMID 6983619. |
|
|
 |
Bouchard, S; Bousquet, C; Roberge, AG (1981). "Characteristics of dihydroxyphenylalanine/5-hydroxytryptophan decarboxylase activity in brain and liver of cat.". Journal of neurochemistry 37 (3): 781-7. PMID 6974228. |
|
|
 |
Gomes P, Soares-da-Silva P. (1999). "L-DOPA transport properties in an immortalised cell line of rat capillary cerebral endothelial cells, RBE 4.". Brain Res. 829 (1-2): 143-150. doi:10.1016/S0006-8993(99)01387-6. PMID 18445233. |
|
|
 |
Bouchard S, Roberge AG (1979). "Biochemical properties and kinetic parameters of dihydroxyphenylalanine--5-hydroxytryptophan decarboxylase in brain, liver, and adrenals of cat". Can. J. Biochem. 57 (7): 1014-8. doi:10.1139/o79-126. PMID 39668. |
|
|
 |
Amamoto T, Sarai K (1976). "On the tryptophan-serotonin metabolism in manic-depressive disorders. Changes in plasma 5-HT and 5-HIAA levels and urinary 5-HIAA excretion following oral loading of L-5HTP in patients with depression". Hiroshima J. Med. Sci. 25 (2-3): 135-40. PMID 1088369. |
|
|
 |
"5-HTP: Uses, Side Effects, Interactions and Warnings - WebMD". http://www.webmd.com/vitamins-supplements/ingredientmono-794-5-HTP.aspx?activeIngredientId=794&activeIngredientName=5-HTP. Retrieved 2009-10-05. |
|
|
 |
"Health.com: 5-hydroxytryptophan : Information on Uses, Dosage & Side Effects on Health.com". http://tools.health.com/natstandardcontent/5-htp-1#H7. Retrieved 2009-10-05.[dead link] |
|
|
 |
Magnussen I, Jensen TS, Rand JH, Van Woert MH (1981). "Plasma accumulation of metabolism of orally administered single dose L-5-hydroxytryptophan in man". Acta pharmacologica et toxicologica 49 (3): 184-9. doi:10.1111/j.1600-0773.1981.tb00890.x. PMID 6175178. |
|
|
 |
Birdsall TC (1998). "5-Hydroxytryptophan: a clinically-effective serotonin precursor". Alternative medicine review : a journal of clinical therapeutic 3 (4): 271-80. PMID 9727088. |
|
|
 |
Sternberg EM, Van Woert MH, Young SN, et al. (1980). "Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa". N. Engl. J. Med. 303 (14): 782-7. doi:10.1056/NEJM198010023031403. PMID 6997735. |
|
|
 |
"5-Hydroxytryptophan". University of Maryland Medical Center.
http://www.umm.edu/altmed/articles/5-hydroxytryptophan-000283.htm. Retrieved 2010-01-21. |
|
|
 |
Caruso I, Sarzi Puttini P, Cazzola M, Azzolini V (1990). "Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome". The Journal of International Medical Research 18 (3): 201-9. PMID 2193835. |
|
|
 |
Trouillas P, Serratrice G, Laplane D, et al. (May 1995). "Levorotatory form of 5-hydroxytryptophan in Friedreich's ataxia. Results of a double-blind drug-placebo cooperative study". Archives of Neurology 52 (5): 456-60. PMID 7733839. http://archneur.ama-assn.org/cgi/pmidlookup?view=long&pmid=7733839. Retrieved 2009-07-30. |
|
|
 |
Birdsall TC (August 1998). "5-Hydroxytryptophan: a clinically-effective serotonin precursor". Alternative Medicine Review : a Journal of Clinical Therapeutic 3 (4): 271-80. PMID 9727088. http://www.thorne.com/altmedrev/.fulltext/3/4/271.pdf. Retrieved 2009-07-30. |
|
|
 |
De Benedittis G, Massei R (1985). "Serotonin precursors in chronic primary headache. A double-blind cross-over study with L-5-hydroxytryptophan vs. placebo". Journal of Neurosurgical Sciences 29 (3): 239-48. PMID 3913752. |
|
|
 |
a b Gustafsson BI, Tømmerås K, Nordrum I, Loennechen JP, Brunsvik A, Solligård E, Fossmark R, Bakke I, Syversen U, Waldum H (March 2005). "Long-term serotonin administration induces heart valve disease in rats". Circulation 111 (12): 1517-22. doi:10.1161/01.CIR.0000159356.42064.48. PMID 15781732. |
|
|
 |
a b Xu J, Jian B, Chu R, Lu Z, Li Q, Dunlop J, Rosenzweig-Lipson S, McGonigle P, Levy RJ, Liang B (December 2002). "Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells". Am. J. Pathol. 161 (6): 2209-18. doi:10.1016/S0002-9440(10)64497-5. PMC 1850896. PMID 12466135.
http://ajp.amjpathol.org/cgi/content/abstract/161/6/2209. |
|
|
 |
PMID 18209781 Joy T, Walsh G, et al. Increase of urinary 5-hydroxyindoleacetic acid excretion but not serum chromogranin A following over-the-counter 5-hydroxytryptophan intake. Can J Gastroenterol. 2008 Jan;22(1):49-53. |
|
|
|
Barney CC, Threatte RM, Kikta DC, Fregly MJ. (June 1981). "Effects of serotonin and L-5-hydroxytryptophan on plasma renin activity in rats.". Pharmacol Biochem Behav. 14 (6): 895-900. doi:10.1016/0091-3057(81)90380-4. PMID 7019933. |
|
|
 |
Ma Z, Zhang G, Jenney C, Krishnamoorthy S, Tao R. (July 2008). "Characterization of serotonin-toxicity syndrome (toxidrome) elicited by 5-hydroxy-l-tryptophan in clorgyline-pretreated rats.". Eur J Pharmacol. 588 (2-3): 198-206. doi:10.1016/j.ejphar.2008.04.004. PMID 18499101. |
|
|
 |
Izumi T, Iwamoto N, Kitaichi Y, Kato A, Inoue T, Koyama T. (2006). "Effects of co-administration of a selective serotonin reuptake inhibitor and monoamine oxidase inhibitors on 5-HT-related behavior in rats.". Eur J Pharmacol. 532 (3): 258-264. doi:10.1016/j.ejphar.2005.12.075. PMID 16488409. |
|
|
 |
Jacobs G, Kamerling I, de Kam M, et al. (Nov 2008). "Enhanced tolerability of the 5-hydroxytryptophane challenge test combined with granisetron". J Psychopharmacol. (Oxford) 24 (1): 65-72. doi:10.1177/0269881108094299. PMID 18719048. |
|
|
 |
http://www.truestarhealth.com/Notes/1339004.html |
|
|
 |
"5 HTP". Web MD. http://www.webmd.com/vitamins-supplements/ingredientmono-794-5-HTP.aspx?activeIngredientId=794&activeIngredientName=5-HTP. Retrieved 8 April 2011. | |
|
|